Catalogo dei prodotti della ricerca

BARONE, EUGENIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.173
EU - Europa 1.119
AS - Asia 324
SA - Sud America 28
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.669
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.145
IT - Italia 627
IN - India 136
SE - Svezia 130
CN - Cina 113
UA - Ucraina 99
FI - Finlandia 59
SG - Singapore 57
GB - Regno Unito 48
FR - Francia 28
AR - Argentina 27
CA - Canada 23
DE - Germania 20
BG - Bulgaria 17
TG - Togo 16
CH - Svizzera 15
IE - Irlanda 15
NL - Olanda 14
BE - Belgio 13
PT - Portogallo 11
HK - Hong Kong 6
PL - Polonia 5
JP - Giappone 4
MX - Messico 4
RO - Romania 4
AL - Albania 3
SC - Seychelles 3
SI - Slovenia 3
EE - Estonia 2
ES - Italia 2
EU - Europa 2
KR - Corea 2
NG - Nigeria 2
TH - Thailandia 2
TR - Turchia 2
AT - Austria 1
BR - Brasile 1
GL - Groenlandia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 5.669
Salva come PNG Salva come JPEG
Città #
Fairfield 783
Ashburn 368
Woodbridge 355
Seattle 307
Rome 280
Cambridge 275
Chandler 268
Houston 262
Wilmington 250
Ann Arbor 168
Princeton 95
San Paolo di Civitate 95
Lawrence 79
Plano 62
Beijing 54
Boston 52
Fasano 44
San Diego 44
Dearborn 43
Millbury 41
Norwalk 38
New York 35
Jacksonville 29
Federal 27
Andover 22
Boardman 17
Milan 17
Lomé 16
Toronto 16
Des Moines 15
Dublin 15
Singapore 14
Sofia 14
Brussels 13
Florence 12
Falls Church 11
Basildon 9
Coimbra 9
Geneva 9
Hefei 9
Redwood City 8
Chicago 7
Kunming 7
Munich 7
Nanjing 7
Naples 7
San Mateo 7
Auburn Hills 6
London 6
Nanchang 6
Bühl 5
Ottawa 5
St Louis 5
Ferentino 4
Helsinki 4
Lanciano 4
Lappeenranta 4
Las Vegas 4
Los Angeles 4
Monfalcone 4
Paris 4
Parmain 4
Phoenix 4
Salerno 4
Zhengzhou 4
Alatri 3
Amsterdam 3
Bern 3
Casale Monferrato 3
Cernobbio 3
Chengdu 3
Cisterna di Latina 3
Edinburgh 3
Fuzhou 3
Guangzhou 3
Mahé 3
Rende 3
Rochester 3
Santa Cruz 3
Tirana 3
Wuhan 3
Abbiategrasso 2
Ariccia 2
Bangkok 2
Bialystok 2
Bremen 2
Buffalo 2
Carrollton 2
Ercolano 2
Fremont 2
Gallarate 2
Istanbul 2
Kilburn 2
Manerba del Garda 2
Mexico City 2
Montemarciano 2
Montreal 2
Morlupo 2
Oeiras 2
Osaka 2
Totale 4.489
Salva come PNG Salva come JPEG
Nome #
Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity 135
Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain 121
Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease 120
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease 117
Curcumin and alzheimer disease: this marriage is not to be performed 111
Lack of p53 Decreases Basal Oxidative Stress Levels in the Brain Through Upregulation of Thioredoxin-1, Biliverdin Reductase-A, Manganese Superoxide Dismutase, and Nuclear Factor Kappa-B 110
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome 107
Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment 99
Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of down's syndrome 99
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome 96
HO-1/BVR-A system analysis in plasma from probable Alzheimer's disease and mild cognitive impairment subjects: A potential biochemical marker for the prediction of the disease 95
Activation of p53 in down syndrome and in the ts65dn mouse brain is associated with a pro-apoptotic phenotype 95
Impairment of biliverdin reductase-a promotes brain insulin resistance in Alzheimer disease: a new paradigm 95
Bach1 overexpression in down syndrome correlates with the alteration of the ho-1/bvr-a system: insights for transition to Alzheimer's disease 94
Inactivation of brain Cofilin-1 by age, Alzheimer's disease and γ-secretase 88
Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: implications for Alzheimer disease 88
Neuropathological role of pi3k/akt/mtor axis in Down syndrome brain 87
Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: novel hints on immunosenescence and biomarker detection 87
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation 87
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease 86
It is all about (U)biquitin: role of altered ubiquitin-proteasome system and UCHL1 in Alzheimer disease 85
Cholesterol-independent neuroprotective and neurotoxic activities of statins: Perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders 84
Disturbance of redox homeostasis in down syndrome: role of iron dysmetabolism 81
Statins more than cholesterol lowering agents in Alzheimer disease: Their pleiotropic functions as potential therapeutic targets. 79
Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways 79
The triangle of death in Alzheimer's disease brain: the aberrant cross-talk among energy metabolism, mammalian target of rapamycin signaling, and protein homeostasis revealed by redox proteomics 79
Intranasal administration of KYCCSRK peptide rescues brain insulin signaling activation and reduces Alzheimer’s disease-like neuropathology in a mouse model for Down syndrome 78
The heme oxygenase/biliverdin reductase pathway in drug research and development 77
Polyubiquitinylation profile in down syndrome brain before and after the development of Alzheimer neuropathology 76
Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease 76
Inhibition of lipid peroxidation and protein oxidation by endogenous and exogenous antioxidants in rat brain microsomes in vitro 75
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome 74
Heme oxygenase-derived carbon monoxide modulates gonadotropin-releasing hormone release in immortalized hypothalamic neurons 72
Curcumin in clinical practice: myth or reality? 70
Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53 70
Poly-ubiquitin profile in Alzheimer disease brain 70
Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment 69
Sex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusion. 69
Coenzyme Q10 and cognition in atorvastatin treated dogs 69
High-fat diet leads to reduced protein o-glcnacylation and mitochondrial defects promoting the development of Alzheimer’s disease signatures 67
In vivo protective effect of ferulic acid against noise-induced hearing loss in the guinea-pig 66
Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects 65
null 64
Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: a harmful synergistic path in down syndrome 64
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease 64
Therapeutic use of tea derivatives: All that glitters is not gold 63
Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus 63
Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants 62
The protective role of carotenoids against 7-keto-cholesterol formation in solution 61
Early and selective activation and subsequent alterations to the unfolded protein response in down syndrome mouse models 61
Synthesis, characterization, and anti-inflammatory activity of diclofenac-bound cotton fibers 60
HNE-modified proteins in Down syndrome: involvement in development of Alzheimer disease neuropathology 60
Ferulic acid and its therapeutic potential as a hormetin for age-related diseases 59
Natural substances and Alzheimer's disease: From preclinical studies to evidence based medicine 58
The BACH1/Nrf2 axis in brain in down syndrome and transition to alzheimer disease-like neuropathology and dementia 58
Pharmacologists and Alzheimer disease therapy: To boldly go where no scientist has gone before 57
Redox Proteomics Analyses of the Influence of Co-Expression of Wild-Type or Mutated LRRK2 and Tau on C. elegans Protein Expression and Oxidative Modification: Relevance to Parkinson Disease 57
Lack of p53 Affects the Expression of Several Brain Mitochondrial Proteins: Insights from Proteomics into Important Pathways Regulated by p53 56
Oxidative and Nitrosative Modifications of Biliverdin Reductase-A in the Brain of Subjects with Alzheimer’s Disease and Amnestic Mild Cognitive Impairment 55
Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain 55
Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control 55
Characterization of the S-denitrosylating activity of bilirubin. 54
Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. 54
The dysregulation of OGT/OGA cycle mediates Tau and APP neuropathology in down syndrome 54
Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: A novel mechanism of action 54
Experimental research on nitric oxide and the therapy of alzheimer disease: A challenging bridge 52
Editorial: Oxidative stress and Alzheimer disease: where do we stand? 51
Chronic perk induction promotes alzheimer-like neuropathology in down syndrome: Insights for therapeutic intervention 50
Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles 50
null 49
Reduced biliverdin reductase-a expression in visceral adipose tissue is associated with adipocyte dysfunction and nafld in human obesity 49
Heme oxygenase expression and activity in immortalized hypothalamic neurons GT1-7 47
Aberrant protein networks in Alzheimer disease 45
BVR-A deficiency leads to autophagy impairment through the dysregulation of AMPK/mTOR axis in the brain—Implications for neurodegeneration 44
Proteomics study of peripheral blood mononuclear cells in down syndrome children 42
Behavioural and neuropathological effects of intranasal insulin treatment in a triple-transgenic mouse model of Alzheimer's disease (3xTg-AD) 40
Down syndrome Is a metabolic disease: altered Insulin signaling mediates peripheral and brain dysfunctions 39
Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes 38
Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain. 36
CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down syndrome 36
Heme oxygenase-1 in central nervous system malignancies 33
Borsa miglior poster 31
Brain insulin resistance: An early risk factor for Alzheimer's disease development in down syndrome 30
Editorial: Brain insulin resistance in neurodevelopmental and neurodegenerative disorders: mind the gap! 29
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease 24
Building the future therapies for down syndrome: the third international conference of the T21 research society 23
mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder 22
Dynamic changes of BVRA protein levels occur in response to insulin: a pilot study in humans 21
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome 20
Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signaling 20
Role of biliverdin reductase A in the regulation of insulin signaling in metabolic and neurodegenerative diseases: An update 19
Valorization of tomato waste as a source of carotenoids 18
Insulin Signaling Regulates Mitochondrial Bioenergetics in the Brain: Insight for the Development of Neurodegenerative Diseases 8
A bioengineering strategy to control ADAM10 activity in living cells 8
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology 7
Engineering memory with an extrinsically disordered kinase 5
Insulin resistance in Alzheimer disease: Is heme oxygenase-1 an Achille's heel? 4
Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model 4
Totale 5.989
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019561 0 0 0 0 0 0 0 0 0 0 319 242
2019/20201.463 170 66 19 88 153 186 218 192 165 106 51 49
2020/2021637 48 59 38 22 29 29 32 36 83 178 62 21
2021/20221.116 68 70 115 28 95 48 43 125 77 70 187 190
2022/20231.068 163 259 61 124 94 83 35 69 102 18 42 18
2023/2024512 47 78 29 40 65 120 30 25 7 47 24 0
Totale 5.989